" /> Hyperparathyroidism, neonatal severe - CISMeF





Preferred Label : Hyperparathyroidism, neonatal severe;

Symbol : NSHPT;

CISMeF acronym : NHPT; NSHPT;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Hyperparathyroidism, neonatal severe primary; Nsph; NHPT;

Description : Neonatal severe hyperparathyroidism usually manifests in the first 6 months of life with severe hypercalcemia, bone demineralization, and failure to thrive. Early diagnosis is critical because untreated NSHPT can be a devastating neurodevelopmental disorder, which in some cases is lethal without parathyroidectomy. Some infants have milder hyperparathyroidism and a substantially milder clinical presentation and natural history (summary by Egbuna and Brown, 2008).;

Inheritance : Autosomal recessive; Autosomal dominant (de novo in some patients);

Molecular basis : Caused by mutation in the calcium-sensing receptor gene (CASR, 601199.0002);

Laboratory abnormalities : Elevated serum parathyroid hormone; Parathyroid chief-cell hyperplasia; Hypophosphatemia; Hypercalcemia; Hyperphosphaturia; Aminoaciduria; Hypercalciuria; Increased urinary cyclic AMP;

Prefixed ID : #239200;

Details


You can consult :


Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.